Sleep Restriction and Stimulus Control for Chronic Insomnia
sleep restriction and stimulus control
+ sleep hygiene education
Mental Disorders+3
+ Sleep Initiation and Maintenance Disorders
+ Nervous System Diseases
Treatment Study
Summary
Study start date: December 1, 2024
Actual date on which the first participant was enrolled.This study focuses on improving sleep quality for individuals with chronic insomnia who spend too much time in bed and have developed poor sleep habits. The research aims to test two strategies: sleep restriction and stimulus control. Sleep restriction involves reducing the amount of time spent in bed to better match the actual time spent sleeping, which can help enhance the efficiency and quality of sleep. Stimulus control is designed to create a stronger mental link between the bed and quickly falling asleep, reducing the negative feelings associated with being in bed but unable to sleep. Participants in the study will undergo a treatment that includes both sleep restriction and stimulus control techniques. These techniques are applied to see if they can help reduce insomnia symptoms and improve overall sleep quality. Sleep restriction involves adjusting the time participants are allowed to spend in bed, while stimulus control includes strategies to help them associate their bed with sleep rather than wakefulness. The study will monitor changes in sleep patterns and efficiency, although specific outcomes are not detailed. The goal is to find effective non-drug treatments for those struggling with chronic insomnia.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.88 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Xuanwu Hospital, Capital Medical University
Beijing, ChinaOpen Xuanwu Hospital, Capital Medical University in Google Maps